What do systematic reviews say?

Intervention not reported

The review found no eligible studies for this question.

• Interval brain imaging for adults with cerebral glioma 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Interval brain imaging for adults with cerebral glioma 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Interval brain imaging for adults with cerebral glioma 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Two doses of HPV vaccine vs three doses of HPV vaccine

The review found no eligible studies for this question.

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Two doses of HPV vaccine with longer interval vs two doses of HPV vaccine with shorter interval

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 16 participants
  Moderate

Two doses of HPV vaccine with longer interval vs two doses of HPV vaccine with shorter interval

The review found no eligible studies for this question.

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Two doses of HPV vaccine with longer interval vs two doses of HPV vaccine with shorter interval

The review found no eligible studies for this question.

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Two doses of HPV vaccine with longer interval vs two doses of HPV vaccine with shorter interval

The review found no eligible studies for this question.

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Two doses of HPV vaccine with longer interval vs two doses of HPV vaccine with shorter interval

The review found no eligible studies for this question.

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Two doses of HPV vaccine with longer interval vs two doses of HPV vaccine with shorter interval

It is very uncertain whether two doses of HPV vaccine with longer interval changes serious adverse events at up to 5‐year compared with two doses of HPV vaccine with shorter interval (very low certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  OR 1.15 [0.55, 2.41]
  1 study · 481 participants
  Very low

Two doses of HPV vaccine with longer interval vs two doses of HPV vaccine with shorter interval

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 481 participants
  Low

Three doses HPV vaccine vs control

The review found no eligible studies for this question.

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Three doses HPV vaccine vs control

Three doses HPV vaccine showed no clear difference in penile or anal intraepithelial neoplasia at up to 3‐year compared with control (low certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  Rate ratio 0.17 [0.01, 3.27]
  1 study · 2805 participants
  Low

Three doses HPV vaccine vs control

Three doses HPV vaccine probably leads to lower external genital lesions (any genotype) at up to 3‐year compared with control (moderate certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  Rate ratio 0.16 [0.07, 0.38]
  1 study · 2545 participants
  Moderate

Two doses of HPV vaccine vs three doses of HPV vaccine

Two doses of HPV vaccine probably leads to lower antibody response (immunogenicity) compared with three doses of HPV vaccine (moderate certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 45 participants
  Moderate

Three doses HPV vaccine vs control

Three doses HPV vaccine probably leads to lower anogenital warts at up to 3‐year compared with control (moderate certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  Rate ratio 0.11 [0.03, 0.38]
  1 study · 2805 participants
  Moderate

Three doses HPV vaccine vs control

Three doses HPV vaccine leads to higher overall local/injection site adverse events at 15‐day compared with control (high certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  RR 1.12 [1.06, 1.18]
  1 study · 3895 participants
  High

Three doses HPV vaccine vs control

Three doses HPV vaccine showed no clear difference in overall systemic events and general symptoms at 15‐day compared with control (moderate certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  RR 0.99 [0.9, 1.08]
  2 studies · 5008 participants
  Moderate

Three doses HPV vaccine vs control

It is very uncertain whether three doses HPV vaccine changes serious adverse events at up to 3‐year compared with control (very low certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  OR 1.48 [0.15, 14.46]
  1 study · 270 participants
  Very low

Three doses HPV vaccine vs control

Three doses HPV vaccine may leads to lower mortality at up to 3‐year compared with control (low certainty).

• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 270 participants
  Low